June 2023 - PsychedelicNewsWire (PNW)

FridayJun 30, 2023 11:22 am

5 Main Takeaways from Denver Psychedelics Conference

The Colorado Convention Center recently hosted the latest iteration of Psychedelic Science, a massive psychedelic-themed event that attracted thousands of attendees from around the world. Psychedelic Science 2023 was the largest psychedelic conference ever held worldwide, bringing in nearly 12,000 attendees from various walks of life and a host of speakers to talk about recent events and breakthroughs in psychedelics. Here are the five main takeaways from the fourth Psychedelic Science event; Psychedelics have caught the eye of a very diverse group of people. The recent conference drew people with a diverse array of backgrounds and interests.mThe exhibition hall, for…

ThursdayJun 29, 2023 11:12 am

NFL Star Says Psychedelics Boosted His Performance

The world is currently in the midst of a psychedelic renaissance that has seen dozens of research teams worldwide dedicate themselves to studying the potential mental health benefits of psychedelic-assisted treatments. Although psychedelic research is still a new field, initial studies and anecdotal reports from users indicate that hallucinogens have many significant mental health benefits. Psychedelics have also enjoyed increased mainstream attention in recent years partly thanks to support from celebrities and public personalities. These celebrity testimonies, endorsements and, in some cases, investments in psychedelic research have significantly increased public interest in psychedelics at a time when the United States…

WednesdayJun 28, 2023 2:37 pm

FDA Issues Draft Guidance for Testing Psychedelics as Mental Health Treatments

The Food and Drug Administration recently released a draft guidance on research protocols for psychedelic substances. This move signals the probable use of these drugs as treatments for mood disorders such as post-traumatic stress disorder and depression. In a statement, Dr. Tiffany Farchione, who oversees the regulation of psychiatric medicines at the FDA, stated that psychedelics had shown promise as possible therapies for anxiety, substance use and mood disorders and added that they were still at the investigational stage. Farchione noted that the agency hoped to outline the issues that arose when developing psychedelic drug-development programs. The draft guidance, she…

TuesdayJun 27, 2023 12:35 pm

Ayahuasca May Have Facilitated Kids’ Rescue in the Amazon

A group of four children that recently went missing in the Amazon forest after a plane crash may owe their rescue to ayahuasca. Some people believe ayahuasca played a role in an almost-divine act of intervention that saw the indigenous volunteers and Colombian army scour the expansive rainforest in a race against time to save the missing children. Ayahuasca is a plant-based psychedelic brew made from hallucinogenic ingredients such as N, N-dimethyltryptamine (DMT). Originating and primarily consumed in Southern America, ayahuasca is said to have neuroprotective, memory-boosting, anti-inflammatory properties. Some studies have also found that the psychedelic can increase mindfulness,…

MondayJun 26, 2023 12:18 pm

Psychedelics Unlock Pivotal Learning Windows, Study Finds

A recent psychedelic study has indicated that hallucinogens such as psilocybin may be able to unlock the critical “learning period” when mammals are more susceptible to their outside environment. This is a period of brain development when mammals can engage with their surroundings in a way that drives brain development and allows them to absorb the lessons they need to survive swiftly. It allows mammals to quickly learn skills that are essential for their survival, such as speech in humans and singing in birds. Finding ways to reopen this period could make it possible and a lot easier for humans…

FridayJun 23, 2023 11:01 am

Denver Psychedelics Conference Draws National Attention

Recent advancements in psychedelic research have placed hallucinogenic drugs at the forefront of mental health treatment research. After researchers spent decades trying to find safer and more effective treatments for mental disorders, psychedelics emerged as a safe and viable treatment for mental ailments. Studies have found that hallucinogens, including psilocybin, MDMA, and ketamine, can treat conditions such as depression and PTSD with minimal side effects. This influx of psychedelic research has brought psychedelics to the forefront of mainstream media and driven a flurry of legislative action in several regions in the country. The upcoming Psychedelic Science conference in Denver will…

ThursdayJun 22, 2023 12:44 pm

NIDA to Fund Studies on Impact of Psychedelics Legalization in Cities, States

Last week, a federal health agency requested that studies into the influence of evolving laws on psychedelics in states and cities across the country be conducted. The National Institute on Drug Abuse (NIDA) issued a notice talking about how the psychedelic reform movement had spread and discussing the different approaches used by various jurisdictions, which included decriminalized, reduced penalties and legalization. The notice of special interest also highlighted the historic win recorded in Oregon a little more than two years ago when voters in the state legalized psilocybin services. The state of Colorado followed suit soon after, establishing healing centers…

WednesdayJun 21, 2023 1:33 pm

Canadian Study Shows Lower Substance Abuse Cases Among Psychedelics Users

A Canadian research team has published findings indicating that psychedelic use may lower substance abuse rates among users. The study, whose findings were reported in the “International Journal of Mental Health and Addiction,” sought to understand changes in patterns of substance abuse among Canadians after they took psychedelics. As in the United States and Australia, Canada has loosened its psychedelic policies in recent years to finally allow researchers to study their potential benefits and risks. These preliminary studies have revealed that several psychedelics can alleviate the symptoms of mental disorders, such as eating disorders, treatment-resistant depression, anxiety and PTSD. As…

TuesdayJun 20, 2023 1:13 pm

Study Shows Trip-Free Psilocybin’s Anti-OCD Effects

Psilocybin is one of several psychedelics that have exhibited therapeutic potential against various common mental disorders. Research has revealed that psilocybin (magic mushrooms) can deliver long-term benefits against mental disorders such as depression, anxiety, and substance-abuse disorders. However, psilocybin-assisted therapy usually involves undergoing a psychedelic trip that can last up to six hours. Given that many people would prefer psychedelic treatments without the hours long trip, researchers have been working to develop psychedelic drugs that allow patients to derive the benefits without having to experience hallucinogenic effects for hours. In a recent study on the effects of trip-free psychedelics, researchers…

FridayJun 16, 2023 1:08 pm

Study Suggests Psychedelics Trigger Psychological Strengths in Users

A recent influx in psychedelic research has revealed that hallucinogenic drugs have the potential to treat a wide variety of mental health disorders. Even though most jurisdictions still outlaw the production and sale of psychedelics, looser psychedelic laws have made it possible for researchers to study the potential benefits and risks of psychedelic use. This research has shown that psychedelics such as psilocybin, MDMA and LSD can offer long-term relief against various mental disorders with minimal side effects. As most psychedelic research is still in its infancy, researchers across the country are working to fully understand the effects of psychedelics…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: June 2023